Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone (GH), does not contain GH sequence and ...

Genescience Pharma Private Limited is a Non-govt company, incorporated on 27 Dec, 2011. It's a private unlisted company and is classified as'company limited by shares'. Company's authorized capital ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by dysregulation in humoral immunity and sustained activation of B cells and autoantibody release, where BAFF (B-cell ...

Phase II study of cemiplimab ± fianlimab following SBRT for oligometastatic clear-cell RCC (LAG-BOOST). This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not ...

DelveInsight's “Endometriosis Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the Endometriosis ...

Endometriosis is a prevalent yet underdiagnosed disease affecting a large population of women of reproductive age, with a substantial and lasting impact on quality of life and fertility. While rising ...

Shanghai Scizeng Medical Technology Co Ltd - a subsidiary of Changchun GeneScience Pharmaceutical Co Ltd (GenSci), RTW Investments, a New York-based global full life-cycle investment firm and Yarrow ...

Shanghai Scizeng Medical Technology, a subsidiary of Changchun GeneScience Pharmaceutical (GenSci), RTW Investments and privately-held US biotech Yarrow Bioscience have announced an exclusive global ...

U.S.-based Yarrow Bioscience is branching out, picking an autoimmune thyroid disease drug from China as its lead candidate. Through a potential $1.37 billion deal, New York-headquartered Yarrow gains ...

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...

Shanghai Scizeng Medical Technology Co., LTD, a subsidiary of Changchun GeneScience Pharmaceutical Co., Ltd. ("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today ...

DelveInsight's 'Thyroid Eye Disease Pipeline Insight 2025' report provides comprehensive global coverage of pipeline thyroid eye disease therapies in various stages of clinical development, major ...